Clinical Trials Logo

Clinical Trial Summary

Vocal nodules represent 16 % of benign vocal fold lesions.They are caused by chronic voice abuse or misuse and often occur in children and adult females. The resultant dysphonia leads to personal, social and occupational problems. The first line of treatment is voice rest and voice therapy. The Accent method is a holistic technique for behavior readjustment voice therapy which targets various voice parameters as loudness, pitch and timbre. However, voice rest and voice therapy are sometimes difficult to be carried out in patients with voice-related occupations. So, complete resolution may not be possible in all patients. When voice therapy is inefficient, resection is performed by laryngeal microsurgery under general anesthesia. However, the role of surgery is much restricted.


Clinical Trial Description

An intralesional steroid injection to vocal nodules has come to the forefront as another treatment choice. Steroids decrease the synthesis and maturation of collagen, suppress fibroblast function, and inhibit the antibacterial phagocytic action of some defense cells and vasoactive substances release.These actions are considered to be functional for treating vocal nodules. Many studies, investigated steroid injection in benign lesions including nodules, reported that 93-100% of the nodules either disappeared or improved. The reported nodules recurrence rate after 2 years was 26.7- 31%. However, to our knowledge, no previous study has compared vocal nodule steroid injection with a group receiving voice therapy to accurately assess the clinical role of vocal fold steroid injection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03914092
Study type Interventional
Source Assiut University
Contact Eman S Hassan, MD
Phone 00201004082014
Email eshh2003@aun.edu.eg
Status Recruiting
Phase Phase 4
Start date September 29, 2019
Completion date September 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05970562 - Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction Early Phase 1
Recruiting NCT04319432 - Optimal Duration of Voice Rest After Surgery for Benign Vocal Lesions N/A